XBIO Xenetic Biosciences Inc
Company Analysis
Latest News
🟢 Xenetic Biosciences is trading 9.83% up today — no direct catalyst confirmed
Xenetic Biosciences is trading 9.83% higher at $1.90, with no direct catalyst for the gain confirmed. - No new company-specific announcement dated October 27...
🟢 Xenetic Biosciences is trading 6.94% up in pre-market
Xenetic Biosciences is trading at $1.85, up 6.94% in pre-market; the reason remains unclear. - No new company-specific announcement dated October 26 or...
🟢 Xenetic Biosciences is trading 19.4% up in after-hours trading with no identified company-specific catalyst
Xenetic Biosciences is trading at $2.06, up 19.36% in after-hours trading; no direct catalyst has been established. - No new company-specific announcement...
🟢 Xenetic Biosciences is trading 8.2% up today alongside gains in S&P 500 and Nasdaq
Xenetic Biosciences is trading at $1.84, up 8.24%, with broader market gains potentially contributing. - No new company-specific announcement dated October 26...
🔴 Xenetic Biosciences is trading 5.2% down with no company-specific catalyst identified
Xenetic Biosciences is trading at $1.83, down 5.18%, with no company-specific catalyst identified. - No company-specific announcement dated October 23, 2026,...
🟢 Xenetic Biosciences is trading 5% up in after-hours trading with no clear company-specific catalyst
Xenetic Biosciences is trading at $2.09, up 5.31%, after closing at $1.98 on October 21; no clear company-specific announcement was identified for the move. -...
🔴 Xenetic Biosciences is trading 7% down with no clear company-specific catalyst identified
Xenetic Biosciences is trading at $1.85, a -7.04% change, with no clear company-specific announcement explaining the October 19 decline. - The latest...
🔴 Xenetic Biosciences is trading 10% down today with no clear company-specific catalyst identified
Xenetic Biosciences is trading 10% down at $1.89, with no clear company-specific catalyst identified. - The company announced that the first patient was dosed...
🔴 Xenetic Biosciences is trading 7% down with no clear company-specific catalyst identified
Xenetic Biosciences is trading at $1.96, down 6.67%, with no clear company-specific catalyst identified. - On October 15, Xenetic announced the first patient...
🔴 Xenetic Biosciences is trading 6.54% down in pre-market with no clear catalyst identified
Xenetic Biosciences is trading at $2.00, down 6.54% in pre-market, with no fresh company announcement explaining the decline. - No fresh October 13 company...
🟢 Xenetic Biosciences rises 5.2% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🟢 Xenetic Biosciences is trading 6.39% up with no clear company-specific catalyst
Xenetic Biosciences is trading at $2.34, up 6.39%, with no clear company-specific catalyst identified for the October 6, 2026 move. - The company’s...
🟢 Xenetic Biosciences is trading 6.61% up in pre-market on October 5, 2026 with no clear catalyst
Xenetic Biosciences is trading at $2.39, up +6.61%, with no clear catalyst identified. - Shares are up from the October 2 close of $2.24. - No October 5...
🔴 Xenetic Biosciences is trading 5.79% down today with biotech-sector weakness as partial context
Xenetic Biosciences is trading 5.79% lower at $2.11, with biotech-sector weakness offering only partial context. - The XBI ETF was down 2.01% pre-market. No...
🔴 Xenetic Biosciences is trading 6.7% down in pre-market as biotech weakness offers partial context
Xenetic Biosciences is trading at $2.09, down 6.68% in pre-market; biotech weakness offers context but does not establish the full cause. - The XBI ETF was...
🔴 Xenetic Biosciences is trading 5.9% down amid possible broad-market pressure
Xenetic Biosciences is trading 5.9% down at $2.25 on September 28, 2026; no company-specific announcement explaining the decline was identified. - The latest...
🔴 Xenetic Biosciences is trading 5.66% down today — no confirmed catalyst identified
Xenetic Biosciences is trading 5.66% lower at $2.33, with no company-specific announcement or confirmed catalyst identified for September 25, 2026. - The stock...
🔴 Xenetic Biosciences is trading 6.48% down in pre-market with no clear catalyst identified
Xenetic Biosciences is trading 6.48% lower at $2.31 in pre-market trading, with no company-specific announcement identified for September 25, 2026. - Recent...
🔴 Xenetic Biosciences is trading 6% down today amid broader risk-off trading
Xenetic Biosciences is trading 5.95% down at $2.37, mainly amid broader risk-off trading, with no clear company-specific announcement identified on September...
🔴 Xenetic Biosciences is trading 7.1% down in pre-market with no clear immediate catalyst
Xenetic Biosciences is trading 7.1% lower at $2.34, with no clear immediate catalyst identified. - No new company-specific announcement was identified for...